The Game-Changing Women of Healthcare
Trailer
Bonus
Episode 10
Season 3
Fighting Rare Diseases with Kinnari Patel and Rocket Pharmaceuticals
Meg and Kinnari discuss the significant impact of genetic testing and drivers for finding cures for rare diseases, the demands and rewards that come with spearheading Rocket Pharmaceuticals, and how true passion has solidified her unwavering commitment to creating a positive impact for rare disease patients.
Kinnari Patel, PharmD is President, Head of Research & Development and Chief Operating Officer of Rocket Pharmaceuticals, a clinical-stage company seeking gene therapy cures for patients with rare diseases. Kinnari has more than 20 years of pharma experience, including stints at Bristol Meyers Squibb, Novartis, Roche, and Pfizer.
Kinnari graduated with a BS in Biology and a Doctor of Pharmacy degree from the University of the Sciences in Philadelphia. She completed an Executive MBA from NYU Stern School of Business and the C-Suite Harvard Business School Advanced Management Program.
Outside of Rocket Pharmaceuticals, Dr. Patel is a member of the Alliance for Regenerative Medicine’s (ARM) Board of Directors and serves on the Healthcare Businesswomen’s Association (HBA) Global Advisory Board.
Further Reading:
Episode Credits: